Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk

Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM.

Biochim Biophys Acta. 2012 Mar;1822(3):442-56. doi: 10.1016/j.bbadis.2011.09.016. Epub 2011 Oct 4.

Nuclear signalling by membrane protein intracellular domains: the AICD enigma

Beckett C, Nalivaeva NN, Belyaev ND, Turner AJ.

Cell Signal. 2012 Feb;24(2):402-409. doi: 10.1016/j.cellsig.2011.10.007. Epub 2011 Oct 17.

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K.

Alzheimers Dement. 2012 Jan;8(1):65-73. doi: 10.1016/j.jalz.2011.07.004. Epub 2011 Nov 2.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2.

CSF biomarkers for amyloid and tau pathology in Alzheimer's disease

Rosenmann H.

J Mol Neurosci. 2012 May;47(1):1-14. doi: 10.1007/s12031-011-9665-5. Epub 2011 Nov 5.

PET amyloid-beta imaging in preclinical Alzheimer's disease

Vlassenko AG, Benzinger TL, Morris JC.

Biochim Biophys Acta. 2012 Mar;1822(3):370-9. doi: 10.1016/j.bbadis.2011.11.005. Epub 2011 Nov 12.

Immune profiling of Alzheimer patients

Pellicanò M, Larbi A, Goldeck D, Colonna-Romano G, Buffa S, Bulati M, Rubino G, Iemolo F, Candore G, Caruso C, Derhovanessian E, Pawelec G.

J Neuroimmunol. 2012 Jan 18;242(1-2):52-9. doi: 10.1016/j.jneuroim.2011.11.005. Epub 2011 Dec 6.

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

Geekiyanage H, Jicha GA, Nelson PT, Chan C.

Exp Neurol. 2012 Jun;235(2):491-6. doi: 10.1016/j.expneurol.2011.11.026. Epub 2011 Dec 1.

Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease

Zhang W, Wang LZ, Yu JT, Chi ZF, Tan L.

J Neurol Sci. 2012 Apr 15;315(1-2):67-71. doi: 10.1016/j.jns.2011.11.032. Epub 2011 Dec 12.

Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets

Osera C, Pascale A, Amadio M, Venturini L, Govoni S, Ricevuti G.

Ageing Res Rev. 2012 Apr;11(2):189-98. doi: 10.1016/j.arr.2011.12.004. Epub 2011 Dec 15.

Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology

Crawford JR, Bjorklund NL, Taglialatela G, Gomer RH.

Neurochem Res. 2012 Apr;37(4):795-801. doi: 10.1007/s11064-011-0674-0. Epub 2011 Dec 29.

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

Wang LL, Huang Y, Wang G, Chen SD.

Med Hypotheses. 2012 Mar;78(3):398-401. doi: 10.1016/j.mehy.2011.11.019. Epub 2011 Dec 29.

Molecular neuroimaging in Alzheimer's disease

Matsuda H, Imabayashi E.

Neuroimaging Clin N Am. 2012 Feb;22(1):57-65, viii. doi: 10.1016/j.nic.2011.11.005. Epub 2011 Dec 6.

Lessons from genome-wide association studies findings in Alzheimer's disease

Moraes CF, Lins TC, Carmargos EF, Naves JO, Pereira RW, Nóbrega OT.

Psychogeriatrics. 2012 Mar;12(1):62-73. doi: 10.1111/j.1479-8301.2011.00378.x. Epub 2011 Oct 27.

The effects of APOE-ε4 on the BOLD response

Trachtenberg AJ, Filippini N, Mackay CE.

Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias